Literature DB >> 28205284

Prognostic impact of complications after resection of early stage hepatocellular carcinoma.

Georgios Antonios Margonis1, Kazunari Sasaki1, Nikolaos Andreatos1, Yujiro Nishioka2, Toshitaka Sugawara2, Neda Amini1, Stefan Buettner1, Masaji Hashimoto2, Junichi Shindoh2, Timothy M Pawlik1.   

Abstract

BACKGROUND: Resection is the most effective treatment for HCC. However, postoperative morbidity is common and its impact on long-term oncological outcome remains unclear.
METHODS: Long-term outcomes of 774 patients who underwent curative resection for early stage HCC at Johns Hopkins Hospital and Toranomon Hospital were investigated after stratifying by the development of postoperative overall and infectious complications.
RESULTS: A minor or major postoperative complication developed in 281 and 65 patients, respectively, while postoperative mortality was 1.3% (n = 10). The 5-year cumulative recurrence and overall survival(OS) rates were 57.2% and 76.4%, respectively. Overall postoperative complications independently predicted worse OS in multivariable analysis (HR = 1.42, P = 0.021). Complication severity did not correlate with OS (P > 0.05). While infectious complications were not independent predictors of OS, the combination of blood transfusion and infectious complications led to significantly worse OS (66.3% vs. 44.9%, P = 0.008). Postoperative complications also correlated with increased recurrence risk, but only in patients with non-cirrhotic parenchyma (55.0% vs. 47.7%, P = 0.035) or non-viral hepatitis (55.6% vs. 44.4%, P = 0.002).
CONCLUSIONS: Post-operative morbidity independently predicted poor OS following hepatectomy for early stage HCC. A similar effect on recurrence was noted only in patients with favorable etiopathologic factors. Finally, the combination of peri-operative transfusion and subsequent infectious complications was associated with a synergistic negative effect on prognosis.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cirrhosis; non-viral hepatitis; transfusion

Mesh:

Year:  2017        PMID: 28205284     DOI: 10.1002/jso.24576

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Clinical Relevance of Reductive Hepatectomy for Barcelona Clinic Liver Cancer Stages B and C Advanced Hepatocellular Carcinoma: A Single-Center Experience of 102 Patients.

Authors:  Shohei Komatsu; Masahiro Kido; Motofumi Tanaka; Kaori Kuramitsu; Daisuke Tsugawa; Masahide Awazu; Hidetoshi Gon; Hirochika Toyama; Kimihiko Ueno; Takumi Fukumoto
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.

Authors:  Stefan Buettner; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Matthew Weiss; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Bas Groot Koerkamp; Shishir K Maithel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-14       Impact factor: 3.452

3.  Minimally Invasive Liver Resection for Early-Stage Hepatocellular Carcinoma: Inconsistent Outcomes from Matched or Weighted Cohorts.

Authors:  Lu Wu; Diamantis I Tsilimigras; Katiuscha Merath; J Madison Hyer; Anghela Z Paredes; Rittal Mehta; Kota Sahara; Fabio Bagante; Eliza W Beal; Feng Shen; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

4.  Duration of Postoperative Fever as a Simple and Useful Prognostic Indicator in Gastric Cancer Patients.

Authors:  Hirohiko Kuroda; Hiroaki Saito; Yuki Murakami; Yuji Shishido; Kozo Miyatani; Tomoyuki Matsunaga; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2021-08-06       Impact factor: 1.641

5.  Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Junjie Kong; Guangbing Li; Jiawei Chai; Guangsheng Yu; Yong Liu; Jun Liu
Journal:  Ann Surg Oncol       Date:  2021-06-23       Impact factor: 5.344

6.  Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials.

Authors:  Hongzhi Liu; Yingchao Wang; Xiaohua Xing; Ying Sun; Dahai Wei; Geng Chen; Qinying Liu; Shanshan Chen; Xiaolong Liu; Jingfeng Liu
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

7.  Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.

Authors:  Gui-Xing Chen; Chao-Ying Qi; Wen-Jie Hu; Xiao-Hui Wang; Yun-Peng Hua; Ming Kuang; Bao-Gang Peng; Shao-Qiang Li
Journal:  BMC Cancer       Date:  2020-05-29       Impact factor: 4.430

8.  A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.

Authors:  Bing Yan; Bing-Bing Su; Dou-Sheng Bai; Jian-Jun Qian; Chi Zhang; Sheng-Jie Jin; Guo-Qing Jiang
Journal:  Cancer Med       Date:  2020-12-06       Impact factor: 4.452

9.  A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.

Authors:  Taiyu He; Tianyao Chen; Xiaozhu Liu; Biqiong Zhang; Song Yue; Junyi Cao; Gaoli Zhang
Journal:  Front Public Health       Date:  2022-01-13

10.  Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications.

Authors:  Noriyuki Hirahara; Takeshi Matsubara; Shunsuke Kaji; Yuki Uchida; Ryoji Hyakudomi; Tetsu Yamamoto; Kiyoe Takai; Yohei Sasaki; Koki Kawakami; Yoshitsugu Tajima
Journal:  Oncotarget       Date:  2022-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.